BAM
PACB icon

Blueshift Asset Management’s Pacific Biosciences PACB Stock Holding History

Blueshift Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,318
Closed -$955K – 1225
2021
Q2 		$955K Buy
+27,318
New +$795K 0.05% 370
2020
Q1 		– Sell
-14,456
Closed -$74K – 537
2019
Q4 		$74K Buy
+14,456
New +$73.5K 0.01% 762
2019
Q3 		– Sell
-14,197
Closed -$86K – 895
2019
Q2 		$86K Sell
14,197
-2,056
-13% -$14.4K 0.01% 677
2019
Q1 		$118K Buy
+16,253
New +$118K 0.02% 641

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return